NCT06054165

Impact of a Clinical Pathway for Pelvic Fragility Fractures

Impact of Regional Implementation of a Clinical Pathway for ELderly Patients With pelVIc Fragility fraCtures (PELVIC); a Multicenter, Stepped-wedge Randomized Controlled Trial

• Status: Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 393 (estimated)
• Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · Academic / Other
• Sex: All
• Age: 50 Years
• Healthy volunteers: Not accepted

Summary

Patients with pelvic fragility fractures suffer from high morbidity and mortality rates. Despite the high incidence of these injuries, there is currently no regional or nationwide treatment protocol which results in a wide variety of clinical practice. New insights in treatment strategies, such as early diagnosis and minimal invasive operative treatment of these fragile patient population, has led to the development of several clinical pathways in recent literature. The aim of this study is to implement an evidence and experience-based treatment clinical pathway to improve the outcomes in this fragile patient population that currently has multifactorial risks for poor outcome.

Conditions

• Pelvic Bone Injury
• Sacral Fracture
• Pelvic Fracture
• Fragility Fracture

Interventions

Type	Name	Description
OTHER	Clinical pathway	Evidence-based and expert-opinion-based clinical pathway regarding the diagnostic and treatment strategy

Timeline

• Start date: 2024-01-21
• Primary completion: 2025-04-27
• Completion: 2027-04-27
• First posted: 2023-09-26
• Last updated: 2024-06-24

Locations

8 sites across 1 country: Netherlands